Reuters
NEW YORK, Nov. 5 /PRNewswire-FirstCall/ -- A new laser therapy that can
potentially remove cataracts from people's eyes more efficiently and with
greater precision was presented on October 24, 2009 at the American Academy of
Ophthalmology (AAO) annual meeting. The technology, currently undergoing
clinical trials outside the USA, was developed by LenSar, a start-up company
which is in a head-to-head competition with two other players to be the first
to commercialize the technology. LenSar plans to start treating patients if
the FDA will consider the results of the remaining trials to be both safe and
effective.